Standardization of sentinel lymph node biopsy in breast carcinoma

Cancer

Volumn 103, Issue 3, 2005, Pages 444-446

  Bold, Richard J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLUE DYE; CYTOKERATIN ANTIBODY; DYE; EOSIN; HEMATOXYLIN; ISOSULFAN BLUE; RADIOACTIVE COLLOID; UNCLASSIFIED DRUG;

ADJUVANT CHEMOTHERAPY; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER STAGING; COLLOID; DIAGNOSTIC ACCURACY; DRUG ADMINISTRATION ROUTE; DRUG DOSE; GERMANY; HEALTH CARE QUALITY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJECTION SITE; LYMPH NODE DISSECTION; LYMPHATIC DRAINAGE; LYMPHATIC DRAINAGE MAPPING; LYMPHOSCINTIGRAPHY; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MEDICAL SOCIETY; MELANOMA; METASTASIS; MOLECULAR BIOLOGY; MOLECULAR TECHNIQUE; NUCLEAR MEDICINE; OUTCOMES RESEARCH; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RETROSPECTIVE STUDY; REVIEW; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SOLID TUMOR; STANDARDIZATION; STATIC LYMPHOSCINTIGRAPHY; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE;

BREAST NEOPLASMS; EUROPE; FEMALE; GERMANY; HUMANS; PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE; SENTINEL LYMPH NODE BIOPSY; UNITED STATES;

EID: 12744277957     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20794     Document Type: Review

References (14)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-398.
3. Bold RJ, Schlieman M, Fahy BN. Sentinel lymph node biopsy for breast cancer. Cancer Biother Radiopharm. 2001;16:347-357.
4. Schwartz GF, Guiliano AE, Veronesi U; Consensus Conference Committee. Proceeding of the consensus conference of the role of sentinel lymph node biopsy in carcinoma or the breast April 19-22, 2001, Philadelphia, PA, USA. Breast J. 2002;8:124-138.
5. American Society of Breast Surgeons. Consensus statement on guidelines for performance of sentinel lymphadenectomy for breast cancer. The American Society of Breast Surgeons. October 19, 2003. Available from URL: http://www.breast surgeons.org/officialstmts/sentinel.shtml [accessed December 12, 2004].
6. Kuehn T, Bembeneck A, Decker T, et al., Consensus Committee of the German Society of Senology. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance. Cancer. 2005;103:451-461.
7. Pendas S, Giuliano R, Swor G, Gardner M, Jakub J, Reintgen DS. Worldwide experience with lymphatic mapping for invasive breast cancer. Semin Oncol. 2004;31:318-323.
8. Goyal A, Mansel RE. Current status of sentinel lymph node biopsy in solid malignancies. World J Surg Oncol. 2004;2:9.
9. Kelley MC, Hansen N, McMasters KM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg. 2004;188:49-61.
10. Tuttle TM. Technical advances in sentinel lymph node biopsy for breast cancer. Am Surg. 2004;70:407-413.
11. McMasters KM, Wong SL, Tuttle TM, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to identify axillary sentinel lymph nodes. Ann Surg. 2000;231:724-731.
12. Viale G, Sonzogni A, Pruneri G, et al. Histopathologic examination of axillary sentinel lymph nodes in breast carcinoma patients. J Surg Oncol. 2004;85:123-128.
13. Cserni G, Amendoeira I, Apostolikas N, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. Clin Pathol. 2004;57:695-701.
14. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-3636.